Chronic heavy drinking drives distinct transcriptional and epigenetic changes in splenic macrophages.


Journal

EBioMedicine
ISSN: 2352-3964
Titre abrégé: EBioMedicine
Pays: Netherlands
ID NLM: 101647039

Informations de publication

Date de publication:
May 2019
Historique:
received: 25 01 2019
revised: 08 04 2019
accepted: 12 04 2019
pubmed: 22 4 2019
medline: 26 11 2019
entrez: 22 4 2019
Statut: ppublish

Résumé

Chronic heavy alcohol drinking (CHD) leads to significant organ damage, increased susceptibility to infections, and delayed wound healing. These adverse outcomes are believed to be mediated by alterations in the function of myeloid cells; however, the mechanisms underlying these changes are poorly understood. We determined the impact of CHD on the phenotype of splenic macrophages using flow cytometry. Changes in functional responses to LPS were measured using luminex and RNA-Seq. Finally, alterations in chromatin accessibility were uncovered using ATAC-Seq. A history of CHD led to increased frequency of splenic macrophages that exhibited a heightened activation state at resting. Additionally, splenic macrophages from CHD animals generated a larger inflammatory response to LPS, both at protein and gene expression levels. Finally, CHD resulted in increased levels of H3K4me3, a histone mark of active promoters, as well as chromatin accessibility at promoters and intergenic regions that regulate inflammatory responses. These findings suggest that a history of CHD alters the immune fitness of tissue-resident macrophages via epigenetic mechanisms. FUND: National Institute on Alcohol Abuse and Alcoholism (NIAAA), National Institutes of Health (NIH) - R24AA019431, U01 AA13641, U01 AA13510, R21AA021947, and R21AA025839.

Sections du résumé

BACKGROUND BACKGROUND
Chronic heavy alcohol drinking (CHD) leads to significant organ damage, increased susceptibility to infections, and delayed wound healing. These adverse outcomes are believed to be mediated by alterations in the function of myeloid cells; however, the mechanisms underlying these changes are poorly understood.
METHODS METHODS
We determined the impact of CHD on the phenotype of splenic macrophages using flow cytometry. Changes in functional responses to LPS were measured using luminex and RNA-Seq. Finally, alterations in chromatin accessibility were uncovered using ATAC-Seq.
FINDINGS RESULTS
A history of CHD led to increased frequency of splenic macrophages that exhibited a heightened activation state at resting. Additionally, splenic macrophages from CHD animals generated a larger inflammatory response to LPS, both at protein and gene expression levels. Finally, CHD resulted in increased levels of H3K4me3, a histone mark of active promoters, as well as chromatin accessibility at promoters and intergenic regions that regulate inflammatory responses.
INTERPRETATION CONCLUSIONS
These findings suggest that a history of CHD alters the immune fitness of tissue-resident macrophages via epigenetic mechanisms. FUND: National Institute on Alcohol Abuse and Alcoholism (NIAAA), National Institutes of Health (NIH) - R24AA019431, U01 AA13641, U01 AA13510, R21AA021947, and R21AA025839.

Identifiants

pubmed: 31005514
pii: S2352-3964(19)30266-X
doi: 10.1016/j.ebiom.2019.04.027
pmc: PMC6557917
pii:
doi:

Substances chimiques

Biomarkers 0
Lipopolysaccharides 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

594-606

Subventions

Organisme : NIAAA NIH HHS
ID : U01 AA013510
Pays : United States
Organisme : NIH HHS
ID : P51 OD011092
Pays : United States
Organisme : NIAAA NIH HHS
ID : U01 AA013641
Pays : United States
Organisme : NIAAA NIH HHS
ID : R21 AA021947
Pays : United States
Organisme : NIAAA NIH HHS
ID : R24 AA019431
Pays : United States
Organisme : NIAAA NIH HHS
ID : R21 AA025839
Pays : United States

Informations de copyright

Copyright © 2019. Published by Elsevier B.V.

Références

Ann N Y Acad Sci. 1975 Apr 25;252:353-64
pubmed: 1056734
Alcohol Clin Exp Res. 2001 Mar;25(3):444-9
pubmed: 11290857
Alcohol Res Health. 2001;25(4):255-61
pubmed: 11910702
J Clin Gastroenterol. 2003 Mar;36(3):242-52
pubmed: 12590237
Alcohol Clin Exp Res. 2003 Nov;27(11):1831-7
pubmed: 14634501
Brain Res Mol Brain Res. 2004 Feb 5;121(1-2):19-27
pubmed: 14969733
Alcohol. 2004 Jun;33(2):147-55
pubmed: 15528012
Alcohol. 2005 Aug;37(1):1-8
pubmed: 16472714
J Immunol. 2006 Jun 15;176(12):7628-35
pubmed: 16751410
Alcohol Clin Exp Res. 2006 Aug;30(8):1436-44
pubmed: 16899048
Alcohol Clin Exp Res. 2007 Jan;31(1):144-55
pubmed: 17207113
J Immunol. 2007 Jun 15;178(12):7686-93
pubmed: 17548605
J Leukoc Biol. 2007 Sep;82(3):752-62
pubmed: 17575268
J Neurosci. 2008 Apr 2;28(14):3729-37
pubmed: 18385331
Alcohol Clin Exp Res. 2008 Sep;32(9):1565-73
pubmed: 18616672
J Leukoc Biol. 2008 Nov;84(5):1335-45
pubmed: 18689673
J Immunotoxicol. 2006 Dec 1;3(4):217-25
pubmed: 18958703
World J Gastroenterol. 2009 Mar 14;15(10):1209-18
pubmed: 19291821
Am J Physiol Lung Cell Mol Physiol. 2009 Jun;296(6):L936-46
pubmed: 19304907
Rev Esp Cardiol. 2009 Jun;62(6):603-5
pubmed: 19480755
J Immunol. 2009 Jul 15;183(2):1320-7
pubmed: 19561104
J Leukoc Biol. 2009 Nov;86(5):1125-34
pubmed: 19675208
World J Gastroenterol. 2010 Mar 21;16(11):1321-9
pubmed: 20238398
AIDS Res Hum Retroviruses. 2010 May;26(5):511-8
pubmed: 20455765
Alcohol Clin Exp Res. 2011 Mar;35(3):392-9
pubmed: 21118273
Alcohol Clin Exp Res. 2011 Mar;35(3):474-83
pubmed: 21118275
Immunol Cell Biol. 2011 Aug;89(6):716-27
pubmed: 21221123
Ann Oncol. 2011 Sep;22(9):1958-72
pubmed: 21307158
Epigenetics. 2011 Sep 1;6(9):1095-104
pubmed: 21814037
Br J Pharmacol. 2012 Mar;165(5):1316-8
pubmed: 21955082
BMC Immunol. 2011 Sep 30;12:55
pubmed: 21962237
Am J Physiol Gastrointest Liver Physiol. 2012 May 1;302(9):G966-78
pubmed: 22241860
J Neurosci. 2012 Feb 1;32(5):1884-97
pubmed: 22302827
Gene. 2012 Apr 25;498(1):5-12
pubmed: 22353363
Nucleic Acids Res. 2012 Jul;40(13):5819-31
pubmed: 22492510
Clin Liver Dis. 2012 Nov;16(4):667-85
pubmed: 23101976
Clin Liver Dis. 2012 Nov;16(4):839-50
pubmed: 23101985
Nat Protoc. 2013 Mar;8(3):627-37
pubmed: 23449255
Cell. 2013 Mar 28;153(1):56-69
pubmed: 23540690
Am J Respir Crit Care Med. 2013 Sep 15;188(6):716-23
pubmed: 23805851
Nat Methods. 2013 Dec;10(12):1213-8
pubmed: 24097267
Alcohol Res. 2013;35(1):6-16
pubmed: 24313160
Alcohol Clin Exp Res. 2014 Apr;38(4):980-93
pubmed: 24329418
Mediators Inflamm. 2014;2014:808695
pubmed: 24623963
Am J Physiol Endocrinol Metab. 2014 May 15;306(10):E1144-54
pubmed: 24691027
J Immunol. 2014 Aug 15;193(4):1975-87
pubmed: 25024384
Proc Natl Acad Sci U S A. 2014 Oct 21;111(42):E4485-93
pubmed: 25288760
Alcohol Clin Exp Res. 2014 Nov;38(11):2835-43
pubmed: 25421519
Adv Exp Med Biol. 2015;815:197-216
pubmed: 25427909
Alcohol. 2015 Feb;49(1):57-64
pubmed: 25572859
Cell Metab. 2015 Jun 2;21(6):805-21
pubmed: 26039447
Genome Res. 2015 Nov;25(11):1757-70
pubmed: 26314830
Cell. 2015 Sep 24;163(1):68-83
pubmed: 26365491
Alcohol Clin Exp Res. 2015 Oct;39(10):1978-88
pubmed: 26380957
J Immunol. 2016 Jan 1;196(1):182-95
pubmed: 26621857
Cell Host Microbe. 2015 Dec 9;18(6):723-35
pubmed: 26651948
Alcohol Res. 2015;37(2):159-70
pubmed: 26695755
Cell Res. 2016 Feb;26(2):151-70
pubmed: 26729620
Alcohol. 2016 Feb;50:43-50
pubmed: 26781212
PLoS One. 2016 Jul 18;11(7):e0159295
pubmed: 27427759
Histopathology. 1989 Mar;14(3):245-53
pubmed: 2785081
Alcohol. 2017 May;60:103-113
pubmed: 27866807
Transl Psychiatry. 2017 Jan 10;7(1):e994
pubmed: 28072409
Neuropharmacology. 2017 Aug 1;122:127-135
pubmed: 28347838
Sci Rep. 2017 Jun 30;7(1):4462
pubmed: 28667254
Psychopharmacology (Berl). 2018 Jan;235(1):109-120
pubmed: 29051997
J Immunol. 2018 Jan 1;200(1):305-315
pubmed: 29150563
Trends Mol Med. 2018 Feb;24(2):144-155
pubmed: 29422263
Handb Exp Pharmacol. 2018;248:369-396
pubmed: 29500721
Gut Microbes. 2018 Jul 4;9(4):338-356
pubmed: 29517944
Blood Adv. 2018 Apr 24;2(8):941-953
pubmed: 29692344
Front Immunol. 2018 May 28;9:1175
pubmed: 29892301
Mol Cell. 2018 Aug 2;71(3):389-397
pubmed: 30075140
Mediators Inflamm. 2018 Jul 24;2018:4658583
pubmed: 30140168
Am J Epidemiol. 1988 Sep;128(3):549-58
pubmed: 3414660
Q J Stud Alcohol. 1972 Mar;33(1):171-85
pubmed: 4551020
Minerva Med. 1969 Dec 19;60(101):5190-4
pubmed: 5362703
Arch Intern Med. 1997 Jul 14;157(13):1446-52
pubmed: 9224223

Auteurs

Suhas Sureshchandra (S)

Department of Molecular Biology and Biochemistry, University of California-Irvine, Irvine, CA 92697, USA.

Cara Stull (C)

Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, OR 97006, USA.

Brian Jin Kee Ligh (BJK)

Department of Biomedical Engineering, University of California-Irvine, Irvine, CA 92697, USA.

Selene Bich Nguyen (SB)

Department of Molecular Biology and Biochemistry, University of California-Irvine, Irvine, CA 92697, USA.

Kathleen A Grant (KA)

Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, OR 97006, USA.

Ilhem Messaoudi (I)

Department of Molecular Biology and Biochemistry, University of California-Irvine, Irvine, CA 92697, USA; Oregon National Primate Research Center, Oregon Health and Science University, Beaverton, OR 97006, USA. Electronic address: imessaou@uci.edu.

Articles similaires

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male
Humans Meals Time Factors Female Adult

Classifications MeSH